Beijing Pioneer Medical Instrument negotiated a license to distribute Olink Bioscience’s Duolink® product line in China. Duolink products are based on Olink’s proximity ligation assay (PLA) technology for the in situ detection of proteins, protein interactions, and modification.
The firm claims that the platform allows target protein detection at single molecule resolution, which means proteins can be studied at normal expression levels in fixed cells and tissue sections. The PLA technology features dual recognition of the analyte in combination with a DNA amplification-based reporter system. This results in unparalleled sensitivity and specificity, according to Olink.
